Stockscreener 앱 받기
7.575
11.30%
-0.965
시간 외 거래:
7.70
0.125
+1.65%
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal
DiaMedica Therapeutics raises capital via share offering - MSN
Trading Action: Why DiaMedica Therapeutics Inc. stock is a value investor pickWeekly Profit Analysis & Low Risk Entry Point Tips - Bộ Nội Vụ
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Nasdaq Moves: Is DiaMedica Therapeutics Inc a cyclical or defensive stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Panic Selling: Can DiaMedica Therapeutics Inc. stock surprise with earnings upsideQuarterly Portfolio Summary & Safe Entry Momentum Stock Tips - Улправда
DiaMedica Therapeutics (NASDAQ:DMAC) Stock Price Down 2.3%Should You Sell? - MarketBeat
What technical charts say about DiaMedica Therapeutics Inc. stockDurability and Wear Notes & HOKA model picks for your routine - ulpravda.ru
Why DiaMedica Therapeutics Inc. stock is a value investor pickRecession Risk & Daily Technical Forecast Reports - ulpravda.ru
DiaMedica Therapeutics (DMAC) Seen as Strong Performer with Upco - GuruFocus
DiaMedica Therapeutics Inc.Common Stock (NQ: DMAC - FinancialContent
DiaMedica Therapeutics sells 1.5 million shares in $12.2 million block trade By Investing.com - Investing.com Nigeria
DiaMedica Therapeutics Raises Capital via Share Offering - TipRanks
DiaMedica Therapeutics sells 1.5 million shares in $12.2 million block trade - Investing.com
A US$59m Drop in the Market Cap of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Is Not What Insiders Like to See After Purchasing Shares Recently - 富途牛牛
DiaMedica Therapeutics (DMAC) price target increased by 25.68% to 15.81 - MSN
Can DiaMedica Therapeutics Inc. stock surprise with earnings upsideTrade Analysis Summary & Growth Focused Stock Pick Reports - Улправда
Craig-Hallum Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC) - The Globe and Mail
DiaMedica Therapeutics provides DM199 update following FDA meeting - MSN
Why DiaMedica Therapeutics Inc. stock attracts high net worth investorsGold Moves & Low Volatility Stock Suggestions - Улправда
Is DiaMedica Therapeutics Inc. stock in correction or buying zone2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - Улправда
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - Nasdaq
DiaMedica (DMAC) Advances with FDA in Preeclampsia Study Plans - GuruFocus
DiaMedica Says FDA Seeks Additional Study Ahead of Pre-IND Submission for Preeclampsia Treatment - marketscreener.com
DiaMedica to conduct additional study for preeclampsia treatment - Investing.com
DiaMedica to conduct additional study for preeclampsia treatment By Investing.com - Investing.com Canada
Diamedica Therapeutics provides DM199 preeclampsia program update - marketscreener.com
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting - TipRanks
DiaMedica Therapeutics Inc Provides DM199 Preeclampsia Program Update - TradingView — Track All Markets
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA - The AI Journal
[8-K] DiaMedica Therapeutics Inc. Reports Material Event | DMAC SEC FilingForm 8-K - Stock Titan
DiaMedica Therapeutics Earnings Notes - Trefis
DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4%Here's Why - MarketBeat
DiaMedica Therapeutics Inc (DMAC) Stock News & Articles - 24/7 Wall St.
Top investors say DiaMedica Therapeutics Inc (DMAC) ticks everything they need - setenews.com
DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year HighTime to Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Diamedica Therapeutics (DMAC) - The Globe and Mail
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Purchases 182,882 Shares of Stock - Defense World
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Buys 187,393 Shares of Stock - Defense World
Jan Stahlberg Acquires 208,872 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,234,453.50 in Stock - MarketBeat
Insider Buying: DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Purchases 128,426 Shares of Stock - MarketBeat
What dividend safety score for DiaMedica Therapeutics Inc. stock2025 Risk Factors & Fast Gain Stock Tips - Newser
What drives DiaMedica Therapeutics Inc stock priceAnalyst Downgrades & Free Lightning Fast Capital Gains - earlytimes.in
4.73%
0.92%
자본화:
|
볼륨(24시간):